Synergistic Modulation of Inflammatory but not Metabolic Effects of High-Fat Feeding by CCR2 and CX3CR1.

Zhang H, Hinkle CC, O'Neill SM, Shi J, Caughey J, Lynch E, Lynch G, Gerelus M, Tsai ASD, Shah R, Ferguson JF, Ahima RS, Reilly MP
Obesity (Silver Spring). 2017 25 (8): 1410-1420

PMID: 28650582 · PMCID: PMC5610963 · DOI:10.1002/oby.21900

OBJECTIVE - The purpose of the study was to explore the impact of dual targeting of C-C motif chemokine receptor-2 (CCR2) and fractalkine receptor (CX3CR1) on the metabolic and inflammatory consequences of obesity induced by a high-fat diet (HFD).

METHODS - C57BL/6J wild-type, Cx3cr1 , Ccr2 , and Cx3cr1 Ccr2 double-knockout male and female mice were fed a 45% HFD for up to 25 weeks starting at 12 weeks of age.

RESULTS - All groups gained weight at a similar rate and developed a similar degree of adiposity, hyperglycemia, glucose intolerance, and impairment of insulin sensitivity in response to HFD. As expected, the circulating monocyte count was decreased in Ccr2 and Cx3cr1 Ccr2 mice but not in Cx3cr1 mice. Flow cytometric analysis of perigonadal adipose tissue of male, but not female, mice revealed trends to lower CD11c+MGL1- M1-like macrophages and higher CD11c-MGL1+ M2-like macrophages as a percentage of CD45+F4/80+CD11b+ macrophages in Cx3cr1 Ccr2 mice versus wild-type mice, suggesting reduced adipose tissue macrophage activation. In contrast, single knockout of Ccr2 or Cx3cr1 did not differ in their adipose macrophage phenotypes.

CONCLUSIONS - Although CCR2 and CX3CR1 may synergistically impact inflammatory phenotypes, their joint deficiency did not influence the metabolic effects of a 45% HFD-induced obesity in these model conditions.

© 2017 The Obesity Society.

MeSH Terms (18)

Animals Body Composition CX3C Chemokine Receptor 1 Diet, High-Fat Female Glucose Intolerance Inflammation Insulin Insulin Resistance Insulin Secretion Macrophages Male Mice Mice, Inbred C57BL Mice, Knockout Obesity Receptors, CCR2 Weight Gain

Connections (1)

This publication is referenced by other Labnodes entities: